Publications of H. Wekerle
All genres
Journal Article (100)
2007
Journal Article
85 (11), pp. 1161 - 1173 (2007)
Experimental models of spontaneous in the central nervous system. Journal of Molecular Medicine-JMM
Journal Article
104 (47), pp. 18625 - 18630 (2007)
Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
104 (3), pp. 920 - 925 (2007)
Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
330 (1), pp. 1 - 12 (2007)
L'énigme de l'entrée des lymphocytes T auto-immuns dans les tissus nerveux centraux et de leur attaque contre les structures de myéline. Comptes Rendus Biologies 2006
Journal Article
27, pp. S1 - S7 (2006)
The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. Neurological Sciences
Journal Article
116 (9), pp. 2385 - 2392 (2006)
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell B cell cooperation. The Journal of Clinical Investigation
Journal Article
103 (32), pp. 12057 - 12062 (2006)
Reconstitution of paired T cell receptor α- and β-chains from microdissected single cells of human inflammatory tissues. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
3 (4), pp. 359 - 367 (2006)
Animal models of multiple sclerosis. Drug Discovery Today: Disease Models
Journal Article
36 (3), pp. 512 - 515 (2006)
Organ specific autoantigens and the autoreactive T cell repertoire: The case of myelin oligodendrocyte glycoprotein. European Journal of Immunology 2005
Journal Article
166 (5), pp. 1441 - 1450 (2005)
Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. American Journal of Pathology
Journal Article
4 (9), pp. 567 - 575 (2005)
Glatiramer acetate in multiple sclerosis: Update on potential mechanisms of action. Lancet Neurology
Journal Article
1, pp. 34 - 44 (2005)
Drug insight: Using monoclonal antibodies to treat multiple sclerosis. Nature Clinical Practice Neurology
Journal Article
201 (11), pp. 1805 - 1814 (2005)
Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. Journal of Experimental Medicine
Journal Article
175 (1), pp. 69 - 81 (2005)
Autoimmune CD4(+) T cell memory: Lifelong persistence of encephalitogenic T cell clones in healthy immune repertoires. Journal of Immunology
Journal Article
201 (2), pp. 195 - 200 (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. Journal of Experimental Medicine
Journal Article
26 (1), pp. S1 - S2 (2005)
Immune pathogenesis of multiple sclerosis. Neurological Sciences
Journal Article
102 (1), pp. 3 - 4 (2005)
Planting and pruning in the brain: MHC antigens involved in synaptic plasticity? Proceedings of the National Academy of Sciences of the United States of America 2004
Journal Article
63 (12), pp. 1284 - 1296 (2004)
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation. Journal of Neuropathology and Experimental Neurology
Journal Article
101 (Suppl. Suppl. 2), pp. 14599 - 14606 (2004)
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
199 (2), pp. 185 - 197 (2004)
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. Journal of Experimental Medicine